Bharat Immunological & Biologicals Corporation Ltd. - Research Center
524663 BIBCL Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Profit before tax | -9.69 | -14.20 | -14.20 | -7.37 | -7.96 |
| Net cashflow-operating activity | -42.12 | 34.08 | 34.08 | -32.20 | 0.25 |
| Net cash used in investing activity | 0.53 | 0.91 | 0.91 | 0.70 | 0.96 |
| Netcash used in fin. activity | 45.00 | -34.41 | -34.41 | 30.71 | -0.32 |
| Net inc/dec in cash and equivlnt | 3.42 | 0.58 | 0.58 | -0.79 | 0.89 |
| Cash and equivalnt begin of year | 1.23 | 0.41 | 0.41 | 1.20 | 0.31 |
| Cash and equivalnt end of year | 4.64 | 0.99 | 0.99 | 0.41 | 1.20 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis